A Souderton firm played a key role in testing Pfizer’s COVID-19 vaccine
Philadelphia Inquirer
While the fanfare surrounding Pfizer’s recently approved COVID-19 vaccine resounds throughout pandemic-stricken America, a Souderton company that played a key role in its journey from test tube to approval is helping scores of other firms in their quests for successful encores.
Since early summer, Almac has been at the heart of the far-flung and intense search for drugs to combat the coronavirus, facilitating trials for the COVID-related products of at least 80 pharmaceutical and bio-tech companies, most notably the Pfizer vaccine that on Dec. 11 won emergency-use authorization from the U.S. Food and Drug Administration.





